Columbia Lab-to-Market Accelerator Network
Overview
Columbia Lab-to-Market Accelerator Network is a university-based accelerator network that provides funding, strategic guidance, and resources to commercialize academic research across deep tech sectors including therapeutics, biomedical technology, carbontech, and advanced materials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Thalo Labs | - | Accelerator | Co-investor |
| Aircela | Feb 2023 | Series A | Co-investor |
| Piki | - | Grant | Co-investor |
| Revora Materials | Dec 2025 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Columbia Lab-to-Market Accelerator Network based?
Columbia Lab-to-Market Accelerator Network is headquartered in New York City, New York, United States.
When was Columbia Lab-to-Market Accelerator Network founded?
Columbia Lab-to-Market Accelerator Network was founded in 2008.
How many portfolio companies does Columbia Lab-to-Market Accelerator Network have?
Columbia Lab-to-Market Accelerator Network has 4 portfolio companies in Caplight's dataset.
What are some companies in Columbia Lab-to-Market Accelerator Network's portfolio?
Portfolio companies visible on Caplight include Thalo Labs, Aircela, Piki, Revora Materials.
What was Columbia Lab-to-Market Accelerator Network's most recent investment shown here?
Columbia Lab-to-Market Accelerator Network's most recent investment in this portfolio sample was in Revora Materials in 2025.
What sectors does Columbia Lab-to-Market Accelerator Network focus on?
Columbia Lab-to-Market Accelerator Network focuses on Media, Entertainment & Gaming, Energy & Sustainability, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, FinTech, Frontier & Industrial Tech.
What company stages does Columbia Lab-to-Market Accelerator Network focus on?
Columbia Lab-to-Market Accelerator Network typically invests at the Early stage.